A biological staging model for operable non-small cell lung cancer

Thorax

Volumn 56, Issue 7, 2001, Pages 561-566

  Cox, G ^b   Jones, J L ^b   Andi, A ^a   Waller, D A ^b   O'Byrne, K J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Matrix metalloproteinases; Non small cell lung cancer

Indexed keywords

CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; PARAFFIN; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034949214     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.7.561     Document Type: Article

References (29)

1. Cancer, cigarette smoking and premature death in Europe: A review including the recommendations of European cancer experts consensus meeting, Helsinki, October 1996
2. Revisions in the international system for staging lung cancer
3. Quantification and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count and computer image analysis
4. Prognostic value of angiogenesis in operable non-small cell lung cancer
5. Angiogenesis as a prospective indicator of survival in non-small-cell lung carcinoma: A prospective study
6. Angiogenesis and non-small cell lung cancer
7. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer
8. Matrix metalloproteinases in tumour invasion and metastasis
9. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
10. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small cell lung cancer
11. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIa non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators in survival
12. Non small cell lung cancer: c-erbB-2 correlates with low angiogenesis and poor prognosis
13. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells
14. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
15. The World Health Organisation histological typing of lung cancer
16. Examining the technique of angiogenesis assessment in invasive breast cancer
17. MMP-9 and the epidermal growth factor receptor signal pathway in operable non-small cell lung cancer
18. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
19. Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor
20. Regulation of matrix metalloproteinase expression in tumor invasion
21. Association between expression of activated 72-kilodalton gelatinase and tumour spread in non-small-cell lung cancer
22. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung
23. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer
24. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
25. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression
26. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
27. Endostatin: An endogenous inhibitor of angiogenesis and tumour growth
28. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat
29. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225